Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
L. El Gharbi, M. S. Maizar, S. Azzabi, J. Ben Ammar, B. Dhahri, M. A. Baccar, S. Toujani, S. Farah, M. Drissa, H. Aouina, H. Bouacha (Tunis, Tunisia). Severe obstructive sleep apnea patients and smoking cessation. Eur Respir J 2009; 34: Suppl. 53, 3707

Member's Comments

No comment yet.

Related content which might interest you: Cigarette smoking in patients with obstructive sleep apnoea (OSA) Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness Year: 2010 Effect of smoking on obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007 Nicotine dependence in tunisian patients with severe obstructive sleep apnea (OSA) Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation Year: 2009 Chronic cough in patients with obstructive sleep apnea. Source: International Congress 2018 – Obesity: comorbidities Year: 2018 Tobacco smoking and the severity of obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2005 - What should we know about our SAS patients Year: 2005 Ato-oxy as the first successful pharmacotherapy for obstructive sleep apnoea Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside Year: 2019 Associated pathologies and tobacco habit in patients diagnosed of obstructive sleep apnoea syndrome treated with nCPAP Source: Eur Respir J 2002; 20: Suppl. 38, 451s Year: 2002 Assessment of the prevalence of obstructive sleep apnea in patients with undiagnosed chronic cough Source: Annual Congress 2012 - Sleep disorders in internal medicine Year: 2012 Predictors of long-term PAP-adherence in obstructive sleep apnea syndrome Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Unrecognised systemic hypertension in patients with obstructive sleep apnoea Source: Eur Respir J 2006; 28: Suppl. 50, 643s Year: 2006 Prevalence of obstructive sleep apnea in patients with difficult-to-treat asthma Source: Annual Congress 2011 - Asthma: risk factors and comorbidities Year: 2011 Unrecognised hypertension in patients screened for obstructive sleep apnoea Source: Eur Respir J 2005; 26: Suppl. 49, 40s Year: 2005 Prolonged symptoms and sleep quality after hospitalization for covid-19 in patients with obstructive sleep apnoea Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing Year: 2021 Prevalence of complex sleep apnea among German patients with obstructive sleep apnea Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009 Recommendations for the management of patients with obstructive sleep apnoea and hypertension Source: Guidelines 2013 Year: 2013 Albuminuria in children with obstructive sleep apnea Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism Year: 2011 Role of CPAP treatment in elderly with moderate obstructive sleep apnea Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 Improving adherence to treatment in patients with obstructive sleep apnoea Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 Obesity and daytime somnolence at patients with obstructive sleep apnea and sistemic hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 562s Year: 2002 Control of breathing in patients with obstructive sleep apnea according to alcohol use Source: Eur Respir J 2001; 18: Suppl. 33, 334s Year: 2001